Anita Pramoda - Jun 1, 2021 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Director
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Jun 1, 2021
Transactions value $
-$339,879
Form type
4
Date filed
6/3/2021, 07:33 PM
Previous filing
May 28, 2021
Next filing
Jun 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Options Exercise $26.7K +2.5K +45.93% $10.66 7.94K Jun 1, 2021 Direct
transaction HCAT Common Stock Sale -$134K -2.5K -31.47% $53.56 5.44K Jun 1, 2021 Direct F1, F2
transaction HCAT Common Stock Sale -$233K -4.35K -52.08% $53.50 4K Jun 1, 2021 By Omkara, LLC(3) F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -2.5K -100% $0.00* 0 Jun 1, 2021 Common Stock 2.5K $10.66 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1.
F2 Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.37 to $54.00, inclusive.
F3 Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.09 to $53.98, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3.
F4 The shares are held by Omkara, LLC and the Reporting Person wholly-owns and holds the voting and dispositive power of these shares.
F5 25% of the 20,000 shares underlying the options vested in an annual installment on April 27, 2018 and the remaining balance vested or will vest in equal monthly installments until the option vested in full on April 27, 2021.